Search for content, post, videos

Sales approval for Vitrolife in the US


The company has received market approval for the time-lapse incubator EmbryoScope+ in the USA, the world’s third largest market measured in terms of number of IVF treatments.

EmbryoScope+ is a time-lapse system with an integrated incubator with a capacity for fifteen patients.

“We are delighted to now being able to offer also EmbryoScope+ to the clinics in the USA”, says Thomas Axelsson, CEO of Vitrolife.